We have a new vaccine against malaria. On October 2nd, 2023, the World Health Organization (WHO) approved R21, a vaccine that showed high efficacy in clinical trials. What’s equally important is that it is a low-cost vaccine that can be mass-manufactured. So, it’s easier to make the millions of doses required to fight malaria in endemic regions, particularly African nations.

The news brings much-needed hope to regions dealing with malaria outbreaks, but other areas may also feel its positive impact. With climate change and globalization, mosq1uito-borne illnesses have been spreading to non-endemic regions as well. An effective Mass Vaccination Campaign can help prevent outbreaks and interrupt transmission world over.

There’s no doubt that the malaria mass vaccination campaign will stand on the shoulders of successful programs prior. Let’s take a look at three such notable mass immunization campaigns through the years, starting with the recent COVID-19 vaccines. Read more on our blog: https://www.gideononline.com/blog/.

The post Successful Mass Vaccination Programs: From Smallpox to COVID-19 appeared first on GIDEON.